Paul J. Hastings, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 1,044 shares at $36.15 ($38K) on 2017-08-22, disclosed to the SEC on 2017-08-24.
Open-market sale of $38k PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NKTX | SELL | 2025-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2025-01-17 | $38K | — | Filing → |
| NKTX | SELL | 2024-06-20 | $10K | — | Filing → |